Kala Pharmaceuticals, Inc. Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350 (Filed With SEC on March 29, 2024)
- Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 29, 2024)
- Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 3, 2023)
- Open Market Sale AgreementSM, dated as of January 19, 2023, by and between Kala Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on January 19, 2023)
- Description of the Registrants Securities Registered under Section 12 of the Exchange Act (Filed With SEC on February 12, 2020)
- Form of Amendment to Offer Letters (Filed With SEC on March 12, 2019)
- Letter Agreement, dated March 25, 2018, by and between the Registrant and Eric Trachtenberg (Filed With SEC on August 9, 2018)
- Letter Agreement, dated November 6, 2017, by and between the Registrant and Todd Bazemore (Filed With SEC on April 2, 2018)
- Amended and Restated Letter Agreement, dated September 10, 2015, by and between the Registrant and Mark Iwicki, as amended by the First Amendment, dated September 28, 2017 (Filed With SEC on November 7, 2017)
- KALA PHARMACEUTICALS, INC. NON-QUALIFIED OPTION AGREEMENT (Filed With SEC on July 10, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on June 23, 2017)
